BR112019016634A2 - polipeptídeos, sequência de polinucleotídeos modificados por engenharia, vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo de fenilalanina amônia liase modificado por engenharia em uma célula hospedeira e para tratar e/ou prevenir os sintomas de fenilcetonúria em um indivíduo, composição, e, uso - Google Patents

Info

Publication number

BR112019016634A2

BR112019016634A2 BR112019016634A BR112019016634A BR112019016634A2 BR 112019016634 A2 BR112019016634 A2 BR 112019016634A2 BR 112019016634 A BR112019016634 A BR 112019016634A BR 112019016634 A BR112019016634 A BR 112019016634A BR 112019016634 A2 BR112019016634 A2 BR 112019016634A2

Authority

BR

Brazil

Prior art keywords

polypeptide

modified

engineered

engineering

pal

Prior art date

2017-02-13

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 394
• 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 391
• 229920001184 polypeptide Polymers 0.000 title claims abstract description 390
• 239000000203 mixture Substances 0.000 title claims abstract description 117
• 102000040430 polynucleotide Human genes 0.000 title claims abstract description 102
• 108091033319 polynucleotide Proteins 0.000 title claims abstract description 102
• 239000002157 polynucleotide Substances 0.000 title claims abstract description 102
• 238000000034 method Methods 0.000 title claims abstract description 68
• 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 title claims description 400
• 201000011252 Phenylketonuria Diseases 0.000 title claims description 29
• 239000013604 expression vector Substances 0.000 title claims description 29
• 208000024891 symptom Diseases 0.000 title claims description 13
• COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 99
• QKHXKQJMUZVCJM-QRPNPIFTSA-N (2s)-2-amino-3-phenylpropanoic acid;azane Chemical class N.OC(=O)[C@@H](N)CC1=CC=CC=C1 QKHXKQJMUZVCJM-QRPNPIFTSA-N 0.000 claims abstract description 42
• 230000002829 reductive effect Effects 0.000 claims abstract description 39
• 230000017854 proteolysis Effects 0.000 claims abstract description 21
• 150000001413 amino acids Chemical group 0.000 claims description 157
• 102000004190 Enzymes Human genes 0.000 claims description 68
• 108090000790 Enzymes Proteins 0.000 claims description 68
• 229940088598 enzyme Drugs 0.000 claims description 68
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 67
• 238000006467 substitution reaction Methods 0.000 claims description 65
• 235000013985 cinnamic acid Nutrition 0.000 claims description 41
• WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 41
• WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 40
• WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 40
• 229930016911 cinnamic acid Natural products 0.000 claims description 40
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 36
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 32
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 32
• 239000012634 fragment Substances 0.000 claims description 27
• 210000004369 blood Anatomy 0.000 claims description 26
• 239000008280 blood Substances 0.000 claims description 26
• 238000011282 treatment Methods 0.000 claims description 24
• 241000078013 Trichormus variabilis Species 0.000 claims description 19
• 108020004705 Codon Proteins 0.000 claims description 18
• 150000001875 compounds Chemical class 0.000 claims description 15
• 108090000317 Chymotrypsin Proteins 0.000 claims description 14
• 108090000631 Trypsin Proteins 0.000 claims description 14
• 102000004142 Trypsin Human genes 0.000 claims description 14
• 229960002376 chymotrypsin Drugs 0.000 claims description 14
• 238000004519 manufacturing process Methods 0.000 claims description 14
• 239000012588 trypsin Substances 0.000 claims description 14
• 239000000499 gel Substances 0.000 claims description 11
• 241000588724 Escherichia coli Species 0.000 claims description 10
• 239000002775 capsule Substances 0.000 claims description 10
• 108020004999 messenger RNA Proteins 0.000 claims description 10
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 8
• 239000007788 liquid Substances 0.000 claims description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 238000001415 gene therapy Methods 0.000 claims description 6
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
• 239000006187 pill Substances 0.000 claims description 6
• 238000002560 therapeutic procedure Methods 0.000 claims description 6
• 239000003826 tablet Substances 0.000 claims description 5
• 102000005367 Carboxypeptidases Human genes 0.000 claims description 4
• 108010006303 Carboxypeptidases Proteins 0.000 claims description 4
• 102000016387 Pancreatic elastase Human genes 0.000 claims description 4
• 108010067372 Pancreatic elastase Proteins 0.000 claims description 4
• 235000005911 diet Nutrition 0.000 claims description 4
• 230000037213 diet Effects 0.000 claims description 4
• 239000000839 emulsion Substances 0.000 claims description 4
• 239000002702 enteric coating Substances 0.000 claims description 4
• 238000009505 enteric coating Methods 0.000 claims description 4
• 238000002347 injection Methods 0.000 claims description 4
• 239000007924 injection Substances 0.000 claims description 4
• 102000004317 Lyases Human genes 0.000 claims description 3
• 108090000856 Lyases Proteins 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 2
• 101150016096 17 gene Proteins 0.000 claims 1
• 101150078635 18 gene Proteins 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 230000035945 sensitivity Effects 0.000 abstract description 22
• 238000003860 storage Methods 0.000 abstract description 15
• 230000001225 therapeutic effect Effects 0.000 abstract description 11
• 230000003197 catalytic effect Effects 0.000 abstract description 10
• 235000001014 amino acid Nutrition 0.000 description 198
• 102200153271 rs786204095 Human genes 0.000 description 178
• 102220326929 rs1555459204 Human genes 0.000 description 164
• 102220125344 rs886043940 Human genes 0.000 description 164
• 102220329435 rs933930437 Human genes 0.000 description 161
• 229940024606 amino acid Drugs 0.000 description 154
• 125000003275 alpha amino acid group Chemical group 0.000 description 153
• 102200153342 rs1555937077 Human genes 0.000 description 148
• 230000000694 effects Effects 0.000 description 134
• 210000004027 cell Anatomy 0.000 description 104
• 102220008236 rs199476327 Human genes 0.000 description 84
• 102220598856 Carboxypeptidase B_L47A_mutation Human genes 0.000 description 78
• 229960005190 phenylalanine Drugs 0.000 description 66
• 235000008729 phenylalanine Nutrition 0.000 description 63
• 108090000623 proteins and genes Proteins 0.000 description 54
• 102220214258 rs1060501302 Human genes 0.000 description 53
• 102000035195 Peptidases Human genes 0.000 description 44
• 108091005804 Peptidases Proteins 0.000 description 44
• 125000000539 amino acid group Chemical group 0.000 description 40
• 239000004365 Protease Substances 0.000 description 38
• 230000014509 gene expression Effects 0.000 description 31
• 235000019419 proteases Nutrition 0.000 description 30
• 150000007523 nucleic acids Chemical class 0.000 description 28
• 102000004169 proteins and genes Human genes 0.000 description 26
• 108091026890 Coding region Proteins 0.000 description 22
• 239000012530 fluid Substances 0.000 description 22
• 235000018102 proteins Nutrition 0.000 description 22
• 102220621869 G-protein coupled estrogen receptor 1_K54I_mutation Human genes 0.000 description 21
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 21
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 21
• 230000000968 intestinal effect Effects 0.000 description 21
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
• 102220510722 Dual specificity tyrosine-phosphorylation-regulated kinase 2_S98G_mutation Human genes 0.000 description 19
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
• 239000013598 vector Substances 0.000 description 18
• 239000006166 lysate Substances 0.000 description 17
• 102000039446 nucleic acids Human genes 0.000 description 17
• 108020004707 nucleic acids Proteins 0.000 description 17
• -1 aliphatic amino acid Chemical class 0.000 description 16
• 238000006243 chemical reaction Methods 0.000 description 16
• XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 16
• 229960001596 famotidine Drugs 0.000 description 16
• 230000035772 mutation Effects 0.000 description 16
• 108010076504 Protein Sorting Signals Proteins 0.000 description 15
• 230000002255 enzymatic effect Effects 0.000 description 15
• 239000000047 product Substances 0.000 description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 description 14
• 230000006872 improvement Effects 0.000 description 14
• 238000012217 deletion Methods 0.000 description 13
• 230000037430 deletion Effects 0.000 description 13
• 238000009472 formulation Methods 0.000 description 13
• 239000001488 sodium phosphate Substances 0.000 description 13
• 229910000162 sodium phosphate Inorganic materials 0.000 description 13
• 239000000758 substrate Substances 0.000 description 13
• 238000012360 testing method Methods 0.000 description 13
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 13
• 102000053602 DNA Human genes 0.000 description 12
• 108020004414 DNA Proteins 0.000 description 12
• 238000002835 absorbance Methods 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 238000009396 hybridization Methods 0.000 description 12
• 238000002703 mutagenesis Methods 0.000 description 12
• 231100000350 mutagenesis Toxicity 0.000 description 12
• 235000002639 sodium chloride Nutrition 0.000 description 12
• 241000894007 species Species 0.000 description 12
• 238000011534 incubation Methods 0.000 description 11
• 208000030159 metabolic disease Diseases 0.000 description 11
• 241000228245 Aspergillus niger Species 0.000 description 10
• 230000002776 aggregation Effects 0.000 description 10
• 238000004220 aggregation Methods 0.000 description 10
• 230000015572 biosynthetic process Effects 0.000 description 10
• 201000010099 disease Diseases 0.000 description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
• 235000013305 food Nutrition 0.000 description 10
• 230000036470 plasma concentration Effects 0.000 description 10
• 239000011780 sodium chloride Substances 0.000 description 10
• 239000000243 solution Substances 0.000 description 10
• 239000003981 vehicle Substances 0.000 description 10
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
• 241000233866 Fungi Species 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 241000282567 Macaca fascicularis Species 0.000 description 9
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
• 230000015556 catabolic process Effects 0.000 description 9
• 229960001031 glucose Drugs 0.000 description 9
• 125000003729 nucleotide group Chemical group 0.000 description 9
• 230000002797 proteolythic effect Effects 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
• 241001465754 Metazoa Species 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 235000015872 dietary supplement Nutrition 0.000 description 8
• 239000008103 glucose Substances 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 239000002773 nucleotide Substances 0.000 description 8
• 239000007787 solid Substances 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
• 108010065511 Amylases Proteins 0.000 description 7
• 240000006439 Aspergillus oryzae Species 0.000 description 7
• 235000002247 Aspergillus oryzae Nutrition 0.000 description 7
• 241000282472 Canis lupus familiaris Species 0.000 description 7
• 102220562239 Disintegrin and metalloproteinase domain-containing protein 11_F16P_mutation Human genes 0.000 description 7
• 229960005091 chloramphenicol Drugs 0.000 description 7
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 7
• 239000008187 granular material Substances 0.000 description 7
• 238000004128 high performance liquid chromatography Methods 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 239000013641 positive control Substances 0.000 description 7
• 230000001105 regulatory effect Effects 0.000 description 7
• 241000351920 Aspergillus nidulans Species 0.000 description 6
• 229910005429 FeSSIF Inorganic materials 0.000 description 6
• 239000004695 Polyether sulfone Substances 0.000 description 6
• 206010001689 alkaptonuria Diseases 0.000 description 6
• 239000013078 crystal Substances 0.000 description 6
• 230000001186 cumulative effect Effects 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 230000008488 polyadenylation Effects 0.000 description 6
• 229920006393 polyether sulfone Polymers 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 102000013142 Amylases Human genes 0.000 description 5
• 244000063299 Bacillus subtilis Species 0.000 description 5
• 235000014469 Bacillus subtilis Nutrition 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 239000002202 Polyethylene glycol Substances 0.000 description 5
• 238000007792 addition Methods 0.000 description 5
• 108090000637 alpha-Amylases Proteins 0.000 description 5
• 235000019418 amylase Nutrition 0.000 description 5
• 230000009286 beneficial effect Effects 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 238000005119 centrifugation Methods 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 239000001963 growth medium Substances 0.000 description 5
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
• 239000011159 matrix material Substances 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 229920001223 polyethylene glycol Polymers 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 5
• 238000012289 standard assay Methods 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
• 239000004382 Amylase Substances 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 241000282693 Cercopithecidae Species 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 4
• 241000192656 Nostoc Species 0.000 description 4
• 102000057297 Pepsin A Human genes 0.000 description 4
• 108090000284 Pepsin A Proteins 0.000 description 4
• 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 4
• 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 4
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 102000004139 alpha-Amylases Human genes 0.000 description 4
• 229940024171 alpha-amylase Drugs 0.000 description 4
• 239000012296 anti-solvent Substances 0.000 description 4
• 125000003118 aryl group Chemical group 0.000 description 4
• 239000012141 concentrate Substances 0.000 description 4
• 235000008504 concentrate Nutrition 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 238000001914 filtration Methods 0.000 description 4
• 239000000787 lecithin Substances 0.000 description 4
• 235000010445 lecithin Nutrition 0.000 description 4
• 229940067606 lecithin Drugs 0.000 description 4
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
• 239000011976 maleic acid Substances 0.000 description 4
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 230000007935 neutral effect Effects 0.000 description 4
• 229940111202 pepsin Drugs 0.000 description 4
• 150000002993 phenylalanine derivatives Chemical class 0.000 description 4
• 229920000058 polyacrylate Polymers 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 239000003755 preservative agent Substances 0.000 description 4
• 235000019833 protease Nutrition 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
• 229910052720 vanadium Inorganic materials 0.000 description 4
• 238000005406 washing Methods 0.000 description 4
• 102000004400 Aminopeptidases Human genes 0.000 description 3
• 108090000915 Aminopeptidases Proteins 0.000 description 3
• 102000004580 Aspartic Acid Proteases Human genes 0.000 description 3
• 108010017640 Aspartic Acid Proteases Proteins 0.000 description 3
• 102100035024 Carboxypeptidase B Human genes 0.000 description 3
• 108090000087 Carboxypeptidase B Proteins 0.000 description 3
• 102000000496 Carboxypeptidases A Human genes 0.000 description 3
• 108010080937 Carboxypeptidases A Proteins 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 102000004860 Dipeptidases Human genes 0.000 description 3
• 108090001081 Dipeptidases Proteins 0.000 description 3
• 108010013369 Enteropeptidase Proteins 0.000 description 3
• 102100029727 Enteropeptidase Human genes 0.000 description 3
• 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
• 241001464427 Gloeocapsa Species 0.000 description 3
• 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 3
• 108700006308 Histidine ammonia-lyases Proteins 0.000 description 3
• 208000026350 Inborn Genetic disease Diseases 0.000 description 3
• 201000006347 Intellectual Disability Diseases 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
• 239000006137 Luria-Bertani broth Substances 0.000 description 3
• 241000192520 Oscillatoria sp. Species 0.000 description 3
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 3
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 3
• 102220472514 Protein ENL_H18R_mutation Human genes 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 241000235403 Rhizomucor miehei Species 0.000 description 3
• BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 3
• 241000187747 Streptomyces Species 0.000 description 3
• 108010052982 Tyrosine 2,3-aminomutase Proteins 0.000 description 3
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
• IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 229910021529 ammonia Inorganic materials 0.000 description 3
• 230000036765 blood level Effects 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 230000000378 dietary effect Effects 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 238000000855 fermentation Methods 0.000 description 3
• 230000004151 fermentation Effects 0.000 description 3
• 208000016361 genetic disease Diseases 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 230000002503 metabolic effect Effects 0.000 description 3
• 230000006320 pegylation Effects 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 238000003259 recombinant expression Methods 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 238000012163 sequencing technique Methods 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• 229960001322 trypsin Drugs 0.000 description 3
• 239000004474 valine Substances 0.000 description 3
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
• 102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 2
• 101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 2
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
• 239000005695 Ammonium acetate Substances 0.000 description 2
• 241000192542 Anabaena Species 0.000 description 2
• 108010037870 Anthranilate Synthase Proteins 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 241000194108 Bacillus licheniformis Species 0.000 description 2
• 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 102220519228 Ciliogenesis and planar polarity effector 1_F16R_mutation Human genes 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• 108090000204 Dipeptidase 1 Proteins 0.000 description 2
• 102000010911 Enzyme Precursors Human genes 0.000 description 2
• 108010062466 Enzyme Precursors Proteins 0.000 description 2
• 241000223218 Fusarium Species 0.000 description 2
• 102000048120 Galactokinases Human genes 0.000 description 2
• 108700023157 Galactokinases Proteins 0.000 description 2
• 101100369308 Geobacillus stearothermophilus nprS gene Proteins 0.000 description 2
• 101100080316 Geobacillus stearothermophilus nprT gene Proteins 0.000 description 2
• 102220537644 Glutathione S-transferase LANCL1_S16A_mutation Human genes 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 239000007995 HEPES buffer Substances 0.000 description 2
• 206010019663 Hepatic failure Diseases 0.000 description 2
• 102220586093 Homeobox protein DLX-1_V39R_mutation Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 244000016296 Jacobaea maritima Species 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• 239000006142 Luria-Bertani Agar Substances 0.000 description 2
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 108010014251 Muramidase Proteins 0.000 description 2
• 102000016943 Muramidase Human genes 0.000 description 2
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
• NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 2
• 102220601563 Putative uncharacterized protein FLJ42102_R59E_mutation Human genes 0.000 description 2
• 208000001647 Renal Insufficiency Diseases 0.000 description 2
• 241000223252 Rhodotorula Species 0.000 description 2
• 241000221523 Rhodotorula toruloides Species 0.000 description 2
• 241001575211 Rivularia <snail> Species 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• 241001001484 Syngonanthus verticillatus Species 0.000 description 2
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
• 239000007983 Tris buffer Substances 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 108010048241 acetamidase Proteins 0.000 description 2
• 239000008186 active pharmaceutical agent Substances 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 150000001298 alcohols Chemical class 0.000 description 2
• 125000001931 aliphatic group Chemical group 0.000 description 2
• 235000019257 ammonium acetate Nutrition 0.000 description 2
• 229940043376 ammonium acetate Drugs 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 238000012219 cassette mutagenesis Methods 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 238000012790 confirmation Methods 0.000 description 2
• 238000002425 crystallisation Methods 0.000 description 2
• 230000008025 crystallization Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 235000007882 dietary composition Nutrition 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 239000012847 fine chemical Substances 0.000 description 2
• 235000019253 formic acid Nutrition 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• 230000002496 gastric effect Effects 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 239000012669 liquid formulation Substances 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000007903 liver failure Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 235000018977 lysine Nutrition 0.000 description 2
• 229960000274 lysozyme Drugs 0.000 description 2
• 239000004325 lysozyme Substances 0.000 description 2
• 235000010335 lysozyme Nutrition 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
• 150000008300 phosphoramidites Chemical class 0.000 description 2
• 229920001451 polypropylene glycol Polymers 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 229920002477 rna polymer Polymers 0.000 description 2
• 102220011745 rs73527759 Human genes 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 238000002864 sequence alignment Methods 0.000 description 2
• 238000012807 shake-flask culturing Methods 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
• UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 238000010189 synthetic method Methods 0.000 description 2
• 239000002562 thickening agent Substances 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
• 229910052721 tungsten Inorganic materials 0.000 description 2
• 150000003668 tyrosines Chemical class 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• 210000005253 yeast cell Anatomy 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• 102220497323 14-3-3 protein zeta/delta_A47D_mutation Human genes 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
• SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
• FVEPUQVTLVLBMB-UHFFFAOYSA-N 5-methylidene-1h-imidazol-4-one Chemical compound C=C1N=CNC1=O FVEPUQVTLVLBMB-UHFFFAOYSA-N 0.000 description 1
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 244000100578 Amorphophallus variabilis Species 0.000 description 1
• 241000534414 Anotopterus nikparini Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 108050008359 Aromatic amino acid lyases Proteins 0.000 description 1
• 102000000050 Aromatic amino acid lyases Human genes 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241001513093 Aspergillus awamori Species 0.000 description 1
• 101900318521 Aspergillus oryzae Triosephosphate isomerase Proteins 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 108090000145 Bacillolysin Proteins 0.000 description 1
• 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
• 108091005658 Basic proteases Proteins 0.000 description 1
• 102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
• 102220615703 Beta-casein_R59D_mutation Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 102220530606 Beta-galactosidase_K73E_mutation Human genes 0.000 description 1
• 101150096674 C20L gene Proteins 0.000 description 1
• 102220469884 CTP synthase 1_K73Q_mutation Human genes 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102000007132 Carboxyl and Carbamoyl Transferases Human genes 0.000 description 1
• 108010072957 Carboxyl and Carbamoyl Transferases Proteins 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 102220582313 Cell cycle regulator of non-homologous end joining_S16M_mutation Human genes 0.000 description 1
• 108010059892 Cellulase Proteins 0.000 description 1
• 108010084185 Cellulases Proteins 0.000 description 1
• 102000005575 Cellulases Human genes 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 206010010904 Convulsion Diseases 0.000 description 1
• 101710199851 Copy number protein Proteins 0.000 description 1
• 102220613502 Creatine kinase M-type_S16Q_mutation Human genes 0.000 description 1
• 244000303965 Cyamopsis psoralioides Species 0.000 description 1
• 102220586640 Cysteinyl leukotriene receptor 1_K54S_mutation Human genes 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• 150000008574 D-amino acids Chemical group 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 102220584607 Endonuclease 8-like 1_K54L_mutation Human genes 0.000 description 1
• 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
• 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
• 101150108358 GLAA gene Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 101150009006 HIS3 gene Proteins 0.000 description 1
• 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
• 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
• 241001480714 Humicola insolens Species 0.000 description 1
• 241001562081 Ikeda Species 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102220497588 InaD-like protein_A47I_mutation Human genes 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• 241000235058 Komagataella pastoris Species 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• 150000008547 L-phenylalanines Chemical class 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 108010029541 Laccase Proteins 0.000 description 1
• 108010059881 Lactase Proteins 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102220617354 Leucine-rich repeat-containing protein 34_V91W_mutation Human genes 0.000 description 1
• 108010036940 Levansucrase Proteins 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 239000006391 Luria-Bertani Medium Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102220466234 MAP kinase-activated protein kinase 3_K73M_mutation Human genes 0.000 description 1
• 101150068888 MET3 gene Proteins 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
• CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
• 102220494360 Methylmalonyl-CoA mutase, mitochondrial_G45D_mutation Human genes 0.000 description 1
• 102220494366 Methylmalonyl-CoA mutase, mitochondrial_H18A_mutation Human genes 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 1
• 229920002274 Nalgene Polymers 0.000 description 1
• 101100022915 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cys-11 gene Proteins 0.000 description 1
• 108091005507 Neutral proteases Proteins 0.000 description 1
• 102000035092 Neutral proteases Human genes 0.000 description 1
• 108090000913 Nitrate Reductases Proteins 0.000 description 1
• 102220484661 Norrin_K54N_mutation Human genes 0.000 description 1
• 241000424623 Nostoc punctiforme Species 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
• 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 108010087702 Penicillinase Proteins 0.000 description 1
• 108030003033 Phenylalanine/tyrosine ammonia-lyases Proteins 0.000 description 1
• 102220539583 Piwi-like protein 1_K73T_mutation Human genes 0.000 description 1
• 102220558805 Platelet-activating factor acetylhydrolase_E18A_mutation Human genes 0.000 description 1
• 108010093965 Polymyxin B Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102220468989 Proline-rich AKT1 substrate 1_A47P_mutation Human genes 0.000 description 1
• 102220502690 Prostaglandin E2 receptor EP1 subtype_S20V_mutation Human genes 0.000 description 1
• 102220630797 Protein KRI1 homolog_V39Q_mutation Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102220575866 Protein argonaute-1_R59K_mutation Human genes 0.000 description 1
• 102220543923 Protocadherin-10_F16L_mutation Human genes 0.000 description 1
• 102220543808 Protoporphyrinogen oxidase_R59G_mutation Human genes 0.000 description 1
• 102220544032 Protoporphyrinogen oxidase_R59W_mutation Human genes 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
• 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 102220579177 SUN domain-containing protein 5_K73I_mutation Human genes 0.000 description 1
• 101900354623 Saccharomyces cerevisiae Galactokinase Proteins 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 101100022918 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sua1 gene Proteins 0.000 description 1
• 102100032491 Serine protease 1 Human genes 0.000 description 1
• 102220529495 Serine/threonine-protein kinase Chk2_K54A_mutation Human genes 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 241000256248 Spodoptera Species 0.000 description 1
• 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
• 241000187432 Streptomyces coelicolor Species 0.000 description 1
• 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
• 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
• 108090000787 Subtilisin Proteins 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
• 102220564325 TIR domain-containing adapter molecule 2_S16E_mutation Human genes 0.000 description 1
• 102220513587 Taste receptor type 2 member 42_V39E_mutation Human genes 0.000 description 1
• 102220484130 Testis-specific serine/threonine-protein kinase 6_K54M_mutation Human genes 0.000 description 1
• PLGPSDNOLCVGSS-UHFFFAOYSA-N Tetraphenylcyclopentadienone Chemical compound O=C1C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PLGPSDNOLCVGSS-UHFFFAOYSA-N 0.000 description 1
• 241000906446 Theraps Species 0.000 description 1
• 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
• 241000223258 Thermomyces lanuginosus Species 0.000 description 1
• 241001313536 Thermothelomyces thermophila Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108090000340 Transaminases Proteins 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 101150050575 URA3 gene Proteins 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 101100445889 Vaccinia virus (strain Copenhagen) F16L gene Proteins 0.000 description 1
• 101100445891 Vaccinia virus (strain Western Reserve) VACWR055 gene Proteins 0.000 description 1
• 102220476885 Vacuolar protein sorting-associated protein 16 homolog_K54D_mutation Human genes 0.000 description 1
• 241000607291 Vibrio fluvialis Species 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 108010045649 agarase Proteins 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 229940025131 amylases Drugs 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 229940069428 antacid Drugs 0.000 description 1
• 239000003159 antacid agent Substances 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 101150009206 aprE gene Proteins 0.000 description 1
• 101150008194 argB gene Proteins 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 102000006635 beta-lactamase Human genes 0.000 description 1
• 235000013361 beverage Nutrition 0.000 description 1
• 239000003139 biocide Substances 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 230000036983 biotransformation Effects 0.000 description 1
• 239000012888 bovine serum Substances 0.000 description 1
• 102220415795 c.161A>G Human genes 0.000 description 1
• 102220431753 c.177G>C Human genes 0.000 description 1
• 102220348035 c.218A>G Human genes 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 229940106157 cellulase Drugs 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 235000015218 chewing gum Nutrition 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 238000005100 correlation spectroscopy Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 101150005799 dagA gene Proteins 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000035418 detection of UV Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 229940079919 digestives enzyme preparation Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 238000011833 dog model Methods 0.000 description 1
• 238000002296 dynamic light scattering Methods 0.000 description 1
• 238000001493 electron microscopy Methods 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 239000003974 emollient agent Substances 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 description 1
• 229960004770 esomeprazole Drugs 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 239000012527 feed solution Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 229930003935 flavonoid Natural products 0.000 description 1
• 150000002215 flavonoids Chemical class 0.000 description 1
• 235000017173 flavonoids Nutrition 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 102000054767 gene variant Human genes 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 239000004009 herbicide Substances 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 108010002685 hygromycin-B kinase Proteins 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 239000002198 insoluble material Substances 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 1
• 229940003703 kuvan Drugs 0.000 description 1
• 229940116108 lactase Drugs 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 239000000865 liniment Substances 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 208000018773 low birth weight Diseases 0.000 description 1
• 231100000533 low birth weight Toxicity 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 101150039489 lysZ gene Proteins 0.000 description 1
• 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 102220515212 mRNA cap guanine-N7 methyltransferase_D55E_mutation Human genes 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000007721 medicinal effect Effects 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 208000004141 microcephaly Diseases 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• 231100000219 mutagenic Toxicity 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 239000002086 nanomaterial Substances 0.000 description 1
• 239000002071 nanotube Substances 0.000 description 1
• 101150095344 niaD gene Proteins 0.000 description 1
• VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
• 229960001721 nitisinone Drugs 0.000 description 1
• OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 description 1
• 101150105920 npr gene Proteins 0.000 description 1
• 101150017837 nprM gene Proteins 0.000 description 1
• 238000010899 nucleation Methods 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 229960000381 omeprazole Drugs 0.000 description 1
• 239000008203 oral pharmaceutical composition Substances 0.000 description 1
• 108090000021 oryzin Proteins 0.000 description 1
• 238000007833 oxidative deamination reaction Methods 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 230000020477 pH reduction Effects 0.000 description 1
• 239000003973 paint Substances 0.000 description 1
• 101150077062 pal gene Proteins 0.000 description 1
• 238000002638 palliative care Methods 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940127557 pharmaceutical product Drugs 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• 150000002994 phenylalanines Chemical class 0.000 description 1
• 229930015704 phenylpropanoid Natural products 0.000 description 1
• 125000001474 phenylpropanoid group Chemical group 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229960003548 polymyxin b sulfate Drugs 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• 235000012015 potatoes Nutrition 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 230000004845 protein aggregation Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 101150108007 prs gene Proteins 0.000 description 1
• 101150086435 prs1 gene Proteins 0.000 description 1
• 101150070305 prsA gene Proteins 0.000 description 1
• 101150054232 pyrG gene Proteins 0.000 description 1
• 238000013102 re-test Methods 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 238000004064 recycling Methods 0.000 description 1
• 235000021067 refined food Nutrition 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 102200029050 rs10407022 Human genes 0.000 description 1
• 102220224889 rs1060502705 Human genes 0.000 description 1
• 102200027732 rs118203925 Human genes 0.000 description 1
• 102220034800 rs118203925 Human genes 0.000 description 1
• 102200115315 rs121918084 Human genes 0.000 description 1
• 102200101053 rs121965073 Human genes 0.000 description 1
• 102200074331 rs122457137 Human genes 0.000 description 1
• 102220283965 rs1426424086 Human genes 0.000 description 1
• 102220280168 rs1428826563 Human genes 0.000 description 1
• 102220072178 rs147447269 Human genes 0.000 description 1
• 102220297470 rs150922490 Human genes 0.000 description 1
• 102220317645 rs1553902356 Human genes 0.000 description 1
• 102220241096 rs1555523987 Human genes 0.000 description 1
• 102220288997 rs1555949009 Human genes 0.000 description 1
• 102200084466 rs17819126 Human genes 0.000 description 1
• 102220110232 rs180724802 Human genes 0.000 description 1
• 102220089846 rs183533911 Human genes 0.000 description 1
• 102220239465 rs199854790 Human genes 0.000 description 1
• 102220254417 rs200128117 Human genes 0.000 description 1
• 102220041065 rs200979664 Human genes 0.000 description 1
• 102220196887 rs367921276 Human genes 0.000 description 1
• 102220009957 rs397507439 Human genes 0.000 description 1
• 102220012912 rs397516363 Human genes 0.000 description 1
• 102200153918 rs41303733 Human genes 0.000 description 1
• 102220094510 rs550945533 Human genes 0.000 description 1
• 102200110418 rs570878629 Human genes 0.000 description 1
• 102220044547 rs587781387 Human genes 0.000 description 1
• 102220045670 rs587782296 Human genes 0.000 description 1
• 102200027714 rs62642946 Human genes 0.000 description 1
• 102200123511 rs72555392 Human genes 0.000 description 1
• 102220226089 rs745771647 Human genes 0.000 description 1
• 102220086058 rs752871324 Human genes 0.000 description 1
• 102200123510 rs756878418 Human genes 0.000 description 1
• 102200153188 rs756928158 Human genes 0.000 description 1
• 102220248953 rs756928158 Human genes 0.000 description 1
• 102220129326 rs765777463 Human genes 0.000 description 1
• 102220264931 rs774900322 Human genes 0.000 description 1
• 102220322137 rs774900322 Human genes 0.000 description 1
• 102220075179 rs796052266 Human genes 0.000 description 1
• 102220075475 rs796052364 Human genes 0.000 description 1
• 101150025220 sacB gene Proteins 0.000 description 1
• FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 description 1
• 229960004617 sapropterin Drugs 0.000 description 1
• RKSUYBCOVNCALL-NTVURLEBSA-N sapropterin dihydrochloride Chemical compound Cl.Cl.N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 RKSUYBCOVNCALL-NTVURLEBSA-N 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 238000009331 sowing Methods 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 235000011149 sulphuric acid Nutrition 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 1
• 230000036962 time dependent Effects 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 101150016309 trpC gene Proteins 0.000 description 1
• 238000005199 ultracentrifugation Methods 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 101150110790 xylB gene Proteins 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1
• 150000008494 α-glucosides Chemical class 0.000 description 1